Stock Scorecard



Stock Summary for Veru Inc (VERU) - $3.25 as of 8/29/2025 9:18:56 PM EST

Total Score

14 out of 30

Safety Score

36 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for VERU

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VERU

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VERU

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for VERU

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for VERU (36 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 10
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for VERU

Veru Announces Novel Modified-Release Oral Formulation for Enobosarm 8/15/2025 1:20:00 PM
Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress 8/12/2025 10:30:00 AM
Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study 8/11/2025 12:30:00 PM
Veru Announces Reverse Stock Split 8/6/2025 12:30:00 PM
Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th 8/5/2025 12:30:00 PM
Veru to Participate in the 2025 BTIG Virtual Biotech Conference 7/22/2025 12:30:00 PM
Veru to Participate in the 2025 BTIG Virtual Biotech Conference - Veru ( NASDAQ:VERU ) 7/22/2025 12:30:00 PM
Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation 6/24/2025 12:30:00 PM
Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation - Veru ( NASDAQ:VERU ) 6/24/2025 12:30:00 PM
Veru to Participate in the Virtual BTIG Obesity Health Forum - Veru ( NASDAQ:VERU ) 6/11/2025 12:30:00 PM

Financial Details for VERU

Company Overview

Ticker VERU
Company Name Veru Inc
Country USA
Description Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 3.25
Price 4 Years Ago 58.90
Last Day Price Updated 8/29/2025 9:18:56 PM EST
Last Day Volume 108,683
Average Daily Volume 914,407
52-Week High 14.20
52-Week Low 2.64
Last Price to 52 Week Low 23.11%

Valuation Measures

Trailing PE 0.55
Industry PE 40.47
Sector PE 60.89
5-Year Average PE -152.30
Free Cash Flow Ratio 3.19
Industry Free Cash Flow Ratio 15.46
Sector Free Cash Flow Ratio 30.76
Current Ratio Most Recent Quarter 2.42
Total Cash Per Share 1.02
Book Value Per Share Most Recent Quarter 1.05
Price to Book Ratio 3.14
Industry Price to Book Ratio 28.68
Sector Price to Book Ratio 26.74
Price to Sales Ratio Twelve Trailing Months 2.85
Industry Price to Sales Ratio Twelve Trailing Months 25.19
Sector Price to Sales Ratio Twelve Trailing Months 13.32
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 14,650,400
Market Capitalization 47,613,800
Institutional Ownership 26.29%

Dividends

Ex-Dividend Date 4/28/2014
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0700
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage -48.15%
3-Year Dividend Growth Rate Percentage -21.98%
5-Year Dividend Growth Rate Percentage -8.53%
All-Time Dividend Growth Rate Percentage -8.53%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 59.42%
Reported EPS 12 Trailing Months 6.00
Reported EPS Past Year -0.63
Reported EPS Prior Year -0.28
Net Income Twelve Trailing Months -32,710,409
Net Income Past Year -37,801,426
Net Income Prior Year -93,152,692
Quarterly Revenue Growth YOY 18.30%
5-Year Revenue Growth -11.89%
Operating Margin Twelve Trailing Months -227.10%

Balance Sheet

Total Cash Most Recent Quarter 15,010,154
Total Cash Past Year 24,916,285
Total Cash Prior Year 9,625,494
Net Cash Position Most Recent Quarter 6,159,362
Net Cash Position Past Year 16,065,493
Long Term Debt Past Year 8,850,792
Long Term Debt Prior Year 8,870,136
Total Debt Most Recent Quarter 8,850,792
Equity to Debt Ratio Past Year 0.79
Equity to Debt Ratio Most Recent Quarter 0.63
Total Stockholder Equity Past Year 32,316,712
Total Stockholder Equity Prior Year 19,678,161
Total Stockholder Equity Most Recent Quarter 15,344,633

Free Cash Flow

Free Cash Flow Twelve Trailing Months -28,981,965
Free Cash Flow Per Share Twelve Trailing Months -1.98
Free Cash Flow Past Year -21,840,655
Free Cash Flow Prior Year -88,679,514

Options

Put/Call Ratio 0.88
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.49
MACD Signal -0.53
20-Day Bollinger Lower Band 3.37
20-Day Bollinger Middle Band 5.17
20-Day Bollinger Upper Band 6.97
Beta -0.71
RSI 34.05
50-Day SMA 6.19
150-Day SMA 16.28
200-Day SMA 37.13

System

Modified 8/28/2025 1:15:15 PM EST